David Davidson's most recent trade in TPG Inc - Ordinary Shares - Class A was a trade of 3,276 TPG Partner Holdings, L.P. Units done . Disclosure was reported to the exchange on Aug. 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2025 | 3,276 | 629,440 | - | - | TPG Partner Holdings, L.P. Units | |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 113 | 13,085 (0%) | 0% | 0 | Common Stock | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2025 | 795 | 795 | - | - | Restricted stock units | |
| Tenax Therapeutics Inc | Michael Davidson Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Loews | Charles D. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 149 | 28,342 (0%) | 0% | 0 | Common Stock | |
| LendingTree Inc | Thomas M. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 5,000 | 0 | - | - | Restricted Stock Units | |
| LendingTree Inc | Thomas M. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2025 | 5,000 | 13,139 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | Thomas M. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| BioAge Labs Inc | Michael Harvey Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Loews | Charles D. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 1,288 | 28,193 (0%) | 0% | 0 | Common Stock | |
| Loews | Charles D. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 1,288 | 0 | - | - | Restricted Stock Units | |
| AES | Janet G. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 15,737 | 91,171 | - | - | Units | |
| AES | Janet G. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2025 | 5,396 | 75,434 | - | - | Units | |
| General American Investors Co | Spencer Davidson | Director, Chairman | Sale of securities on an exchange or to another person at price $ 24.82 per share. | 08 May 2025 | 17,400 | 5,000 | - | 24.8 | 431,910 | 5.95% Preferred Stock |
| BlackLine Inc | Scott J. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 3,776 | 4,444 (0%) | 0% | 0 | Common Stock | |
| First Horizon Corporation | Wendy P. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 14,196 | 96,816 (0%) | 0% | 0 | Common Stock | |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 3,355 | 12,972 (0%) | 0% | 0 | Common Stock | |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2025 | 78 | 9,617 (0%) | 0% | 0 | Common Stock | |
| Sonder Holdings Inc Ordinary | Francis Davidson | Director, Chief Executive Officer | 11 Apr 2025 | 595,000 | 2,095,000 | - | - | Series A Convertible Preferred Stock | ||
| Par Pacific Holdings Inc | Philip Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2025 | 1,935 | 1,935 | - | - | Restricted stock units | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Other type of transaction at price $ 12.92 per share. | 05 Apr 2025 | 440 | 7,613 (0%) | 0% | 12.9 | 5,685 | Common stock |
| Par Pacific Holdings Inc | Philip Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2025 | 440 | 440 | - | - | Restricted stock units | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 41,788 | 41,788 | - | - | Phantom Stock | |
| General American Investors Co | Spencer Davidson | Director, Chairman | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 01 Apr 2025 | 11,199 | 22,400 | - | 24.8 | 278,047 | 5.95% Preferred Stock |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 38,394 | 402,699 | - | 0 | Ordinary Shares | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 38,394 | 0 | - | - | Restricted Stock Unit | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 38,394 | 38,394 | - | - | Restricted Stock Unit | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 30,992 | 364,305 | - | 0 | Ordinary Shares | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 26 Mar 2025 | 12,258 | 390,441 | - | - | Ordinary Shares | |
| Broadway Financial Corp | Robert C. Davidson | Director | Grant, award, or other acquisition of securities at price $ 7.23 per share. | 24 Mar 2025 | 2,904 | 18,452 (0%) | 0% | 7.2 | 20,996 | Common Stock |
| BlackLine Inc | Scott J. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 668 | 668 (0%) | 0% | 0 | Common Stock | |
| Federal Agricultural Mortgage | Richard H. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 376 | 14,178 (0%) | 0% | 0 | Class C Non-Voting Common Stock | |
| FMC Corp | Carol Anthony Davidson | Director | Purchase of securities on an exchange or from another person at price $ 37.33 per share. | 05 Mar 2025 | 6,000 | 6,000 (0%) | 0% | 37.3 | 223,987 | Common Stock |
| Sonder Holdings Inc Ordinary | Francis Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 643,208 | 1,217,287 | - | 0 | Common Stock | |
| Sonder Holdings Inc Ordinary | Francis Davidson | Director, Chief Executive Officer | 04 Mar 2025 | 560,937 | 1,135,016 | - | 0 | Common Stock | ||
| Fractyl Health Inc | Lisa A. Davidson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 174,700 | 174,700 | - | - | Stock Option (right to buy) | |
| Fractyl Health Inc | Lisa A. Davidson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 91,500 | 91,500 | - | - | Stock Option (right to buy) | |
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 170 | 626,164 | - | - | TPG Partner Holdings, L.P. Units | |
| UMB Financial Corp | Janine A. Davidson | Director | Grant, award, or other acquisition of securities at price $ 117.90 per share. | 31 Jan 2025 | 678 | 4,040 (0%) | 0% | 117.9 | 79,936 | Common Stock |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 67 | 9,539 (0%) | 0% | 0 | Common Stock | |
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2025 | 9,550 | 37,861 | - | - | Class A Common Stock | |
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.40 per share. | 13 Jan 2025 | 2,680 | 28,311 | - | 62.4 | 167,232 | Class A Common Stock |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 670,467 | 670,467 | - | - | Option (right to buy) | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 123,529 | 123,529 | - | - | Ordinary Shares | |
| Silence Therapeutics Plc ADR | Michael Harvey Davidson | Director | 02 Jan 2025 | 48,000 | 48,000 | - | - | Share Option (Right to Buy) | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 31,774 | 123,241 (0%) | 0% | - | Common Stock | |
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2025 | 31,774 | 31,774 | - | - | Restricted Share Units | |
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.15 per share. | 01 Jan 2025 | 12,933 | 110,308 (0%) | 0% | 6.2 | 79,538 | Common Stock |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Sale or transfer of securities back to the company at price $ 4.26 per share. | 15 Dec 2024 | 5,220 | 391,100 (3%) | 0% | 4.3 | 22,216 | Common Stock |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 5,220 | 0 | - | - | Phantom Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 5,220 | 396,320 (3%) | 0% | - | Common Stock | |
| Tenax Therapeutics Inc | Davidson Michael Harvey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Zymeworks BC Inc | Davidson Nancy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| TE Connectivity | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2024 | 1,327 | 17,888 (0%) | 0% | 0 | Common Shares | |
| TE Connectivity | Carol Anthony Davidson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 153.25 per share. | 14 Nov 2024 | 556 | 17,332 (0%) | 0% | 153.3 | 85,207 | Common Shares |
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 3,000 | 625,994 | - | - | TPG Partner Holdings, L.P. Units | |
| Sonder Holdings Inc Ordinary | Francis Davidson | Director, Chief Executive Officer | 06 Nov 2024 | 500,000 | 1,500,000 | - | - | Series A Convertible Preferred Stock | ||
| TPG Inc Ordinary Shares | Martin Davidson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2024 | 812 | 622,994 | - | - | TPG Partner Holdings, L.P. Units | |
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 28 Oct 2024 | 155,201 | 155,201 | - | - | Restricted Share Units | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 25 Oct 2024 | 42,071 | 112,987 (0%) | 0% | - | Common Stock | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 25 Oct 2024 | 42,071 | 84,143 | - | - | Restricted Share Units | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 25 Oct 2024 | 21,520 | 91,467 (0%) | 0% | 8.4 | 180,553 | Common Stock | |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2024 | 49 | 9,472 (0%) | 0% | 0 | Common Stock | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Oct 2024 | 15,000 | 85,000 | - | - | Warrant (right to buy) | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2024 | 1,318 | 1,318 | - | - | Restricted stock units | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2024 | 591 | 591 | - | - | Restricted stock units | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Other type of transaction at price $ 18.97 per share. | 05 Oct 2024 | 591 | 6,607 (0%) | 0% | 19.0 | 11,211 | Common stock |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,054 | 15,510 (0%) | 0% | 0 | Common Stock | |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,054 | 16,564 (0%) | 0% | 0 | Common Stock | |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,054 | 1,054 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Sep 2024 | 1,054 | 0 | - | - | Restricted Stock Unit (RSU) | |
| Beam Global | Peter Warner Davidson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 23 Sep 2024 | 10,080 | 10,081 (0%) | 0% | 0 | Common Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 5,224 | 396,324 (3%) | 0% | - | Common Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2024 | 5,224 | 5,220 | - | - | Phantom Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Sale or transfer of securities back to the company at price $ 6.80 per share. | 15 Sep 2024 | 5,224 | 391,100 (3%) | 0% | 6.8 | 35,523 | Common Stock |
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 09 Sep 2024 | 100 | 100 (0%) | 0% | 8.3 | 830 | Common Stock | |
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 06 Sep 2024 | 11,915 | 75,224 (0%) | 0% | - | Common Stock | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 06 Sep 2024 | 11,915 | 11,916 | - | - | Restricted Share Units | ||
| Hain Celestial Group Inc | Wendy P. Davidson | Director, President and CEO | 06 Sep 2024 | 4,308 | 70,916 (0%) | 0% | 8.5 | 36,489 | Common Stock | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 16.27 per share. | 20 Aug 2024 | 5,000 | 209,784 | - | 16.3 | 81,350 | Ordinary Shares |
| Sonder Holdings Inc Ordinary | Francis Davidson | Director, Chief Executive Officer | 13 Aug 2024 | 1,000,000 | 1,000,000 | - | - | Series A Convertible Preferred Stock | ||
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 47,500 | 47,500 | - | - | Pre-Funded Warrant | |
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 25,000 | 25,000 | - | - | Warrant | |
| Tenax Therapeutics Inc | Michael Harvey Davidson | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 08 Aug 2024 | 2,500 | 2,881 (0%) | 0% | - | Common Stock | |
| Beam Global | Peter Warner Davidson | Director | Grant, award, or other acquisition of securities at price $ 6.20 per share. | 31 Jul 2024 | 20,161 | 73,270 (1%) | 0% | 6.2 | 124,998 | Common Stock |
| FMC Corp | Carol Anthony Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2024 | 56 | 9,423 (0%) | 0% | 0 | Common Stock | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2024 | 1,015 | 1,015 | - | - | Restricted stock units | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Other type of transaction at price $ 24.62 per share. | 05 Jul 2024 | 740 | 5,554 (0%) | 0% | 24.6 | 18,219 | Common stock |
| Par Pacific Holdings Inc | Philip Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 740 | 740 | - | - | Restricted stock units | |
| Par Pacific Holdings Inc | Philip Davidson | Director | Other type of transaction at price $ 24.62 per share. | 05 Jul 2024 | 462 | 6,016 (0%) | 0% | 24.6 | 11,374 | Common stock |
| Par Pacific Holdings Inc | Philip Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jul 2024 | 462 | 462 | - | - | Restricted stock units | |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,054 | 2,108 | - | - | Restricted Stock Unit (RSU) | |
| Trupanion Inc | Jacqueline L. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jun 2024 | 1,054 | 14,456 (0%) | 0% | 0 | Common Stock | |
| NewAmsterdam Pharma Company NV | Michael Harvey Davidson | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 17.26 per share. | 20 Jun 2024 | 5,000 | 204,784 | - | 17.3 | 86,309 | Ordinary Shares |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 5,224 | 396,324 (3%) | 0% | - | Common Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 5,224 | 10,444 | - | - | Phantom Stock | |
| Natural Health Trends Corp | Timothy S. Davidson | Sr. V.P. & CFO | Sale or transfer of securities back to the company at price $ 6.80 per share. | 15 Jun 2024 | 5,224 | 391,100 (3%) | 0% | 6.8 | 35,523 | Common Stock |
| LendingTree Inc | Thomas M. Davidson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| LendingTree Inc | Thomas M. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 4,000 | 8,139 (0%) | 0% | - | Common Stock | |
| LendingTree Inc | Thomas M. Davidson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Jun 2024 | 4,000 | 0 | - | - | Restricted Stock Units | |
| Broadway Financial Corp | Robert C. Davidson | Director | Grant, award, or other acquisition of securities at price $ 4.84 per share. | 22 May 2024 | 2,479 | 15,548 (0%) | 0% | 4.8 | 11,998 | Common Stock |